Skip to main content
. 2021 Sep 16;12:5473. doi: 10.1038/s41467-021-25383-z

Fig. 7. In vivo evaluation of PEG-PAMDA coatings on spine surgery model with vancomycin.

Fig. 7

a Synthetic scheme for PAMDA synthesis. b Chemical crosslinking mechanism of tetra-PEG-SH and PAMDA. c In vitro release of vancomycin from PEG-PAM single layer coating and 3 PEG-PAMDA layers coating. d Representative X-ray image of spine surgery model (e) Postoperative in vivo S. aureus bioluminescence signals (mean maximum flux [photons/sec/cm2/sr] (logarithmic scale) of single-layer PEG-PAM only and PEG-PAM with vancomycin on stainless spine implant. (n = 3 for PEG-PAM group, n = 3 for PEG-PAM + Vanc group). f Representative in vivo S. aureus bioluminescence on a color scale overlaid on grayscale images of PEG-PAM with vancomycin and PEG-PAM only groups of POD 0, 3, and 21. g Postoperative in vivo S. aureus bioluminescence signals (mean maximum flux [photons/sec/cm2/sr] (logarithmic scale)) of 3 layers PEG-PAMDA only and 3 layers PEG-PAMDA with vancomycin on stainless spine implant (n = 6 for 3 layers PEG-PAMDA group, n = 6 for 3 layers PEG-PAMDA + Vanc group). h Representative in vivo S. aureus bioluminescence on a color scale overlaid on grayscale images of 3 layers PEG-PAMDA with vancomycin and 3 layers PEG-PAMDA only groups of POD 0, 3, and 21. Statistics in (c, e, g) are a two-way-repeated measure-ANOVA with multiple comparisons post-test. The significance between treatment groups was not significant for (c) and (e) and *p = 0.0116 for (g) Data is plotted showing the Standard Error of the Mean for time longitudinal plots.